On July 11, Gelunhui announced that Simcere Pharma (02096.HK) would repurchase 0.7 million shares for HKD 3.932 million on July 11, 2024, at a repurchase price per share of HKD 5.57-5.65.
先声药业(02096.HK)7月11日耗资393.2万港元回购70万股
Xiansheng Pharmaceutical (02096.HK) spent 3.932 million Hong Kong dollars on July 11th to repurchase 0.7 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.